Art and Science: Credit Valuation Challenge II

Page 3

Page 3
Page 3

Art and Science: Credit Valuation Challenge II

Page 2

Page 3

More so, the rise in capital adequacy requirements and the instruments eligible for counting against CVA charges can push institutions into inadvisable procedures, a potential unintended source of systemic risk. “I’d say the fact that to achieve capital relief incentivizes banks to stop hedging certain risks, which are easily hedge-able, and attempt to hedge even illiquid credit risks, is the biggest worry,” says Gregory.

Onerous Costs
As the credit market for counterparties that may be small or mid-sized is illiquid at best, systemic risk is therefore engendered from those who choose not to hedge the CVA due to onerous costs and keep the risk on their books.

A briefing note from the Association for Financial Markets in Europe, issued following the Basel recommendations, reads: “A consequence of this approach is that institutions that use effective hedges for exposure to reduce exposure volatility but that are not considered eligible for CVA risk capital are subject to higher capital requirements compared to institutions that choose not to hedge their CVA risk. This may result in institutions choosing to carry higher risk in order to avoid penal capital requirements.”

Also important for the computing of regulatory CVA is the inclusion of “wrong-way” risk, defined by the International Swaps and Derivatives Association (ISDA) as risk that occurs when default risk and credit exposure increase together. As well as the computational loads associated with risk calculation, stress-testing and scenario analysis are integral parts of satisfying wrong-way risk mandates. Various stochastic equations, those that measure seemingly random behaviors, have been developed by academics to integrate wrong-way risk with CVA calculations, with standardized stress-tests quantifying CVA changes for areas such as credit, stressed market data, volatility, mean reversion, and other areas.

Salient Points

  • While credit valuation adjustment (CVA) in itself is a demanding technical operation at the best of times, hedging CVA requires further investment both in multi-asset trading software, and advanced computational methods to factor in wider volatility data.
  • Basel III expands on its previous iteration's requirements for counterparty credit risk management, increasing costs and changing the equation with the addition of Value-at-Risk (VaR) to CVA calculations. While the standard prescription is relatively simple, technical challenges occur with the use of internal models and the advanced calculation.
  • For larger banks, centralized CVA desks are the practical solution for managing the problem, as well as for hedging it, although further advanced quantitative groups will also be required for simulating proxies when dealing with counterparties for which credit spread information isn't readily available, or which don't have their own CDS for default protection.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Enough with the ‘Bloomberg Killers’ already

Waters Wrap: Anthony interviews LSEG’s Dean Berry about the Workspace platform, and provides his own thoughts on how that platform and the Terminal have been portrayed over the last few months.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here